Health Care & Life Sciences » Biotechnology | QuantRx Biomedical Corp.

QuantRx Biomedical Corp.

QuantRx Biomedical Corp.
Stock Exchange Other OTC
Market Cap
$393.48 K
Shares Outstanding
78.7 M
Public Float
63.94 M


10190 SW 90th Avenue
Tualatin Oregon 97123
United States
Employees -
Updated 07/08/2019
QuantRx Biomedical Corp. engages in the development and commercializing of patented miniform pads (PAD) and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and medical needs. Its platforms include inSync(R), Unique(TM), PadKit(R), and OEM branded over-the-counter and laboratory testing products. The company was founded on December 5, 1986 and is headquartered in Tualatin, OR.


View All

Shalom Z. Hirschman
Chairman, CEO & Principal Financial Officer
Michael S. Abrams